DNLI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Denali Therapeutics Inc (DNLI).


$2.93B Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

DNLI Market Cap. (MRY)


DNLI Shares Outstanding (MRY)


DNLI Assets (MRY)


Total Assets

$1.37B

Total Liabilities

$144.50M

Total Investments

$1.02B

DNLI Income (MRY)


Revenue

$0

Net Income

-$422.77M

Operating Expense

$487.34M

DNLI Cash Flow (MRY)


CF Operations

-$347.69M

CF Investing

-$88.76M

CF Financing

$484.30M

DNLI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

DNLI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$1,374,180,000 (19.09%)

$1,153,917,000 (-20.98%)

$1,460,242,000 (3.99%)

$1,404,162,000 (-12.47%)

Assets Current

$864,436,000 (-18.77%)

$1,064,137,000 (-22.46%)

$1,372,319,000 (52.95%)

$897,234,000 (-40.01%)

Assets Non-Current

$509,744,000 (467.77%)

$89,780,000 (2.11%)

$87,923,000 (-82.66%)

$506,928,000 (366.68%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$1,229,684,000 (19.28%)

$1,030,954,000 (-1.10%)

$1,042,430,000 (8.33%)

$962,291,000 (-16.36%)

Property Plant & Equipment Net

$125,630,000 (75.37%)

$71,637,000 (-3.87%)

$74,524,000 (7.06%)

$69,608,000 (-5.25%)

Cash & Equivalents

$174,960,000 (37.65%)

$127,106,000 (-41.71%)

$218,044,000 (-25.70%)

$293,477,000 (-42.13%)

Accumulated Other Comprehensive Income

$2,020,000 (214.15%)

$643,000 (109.34%)

-$6,886,000 (-175.55%)

-$2,499,000 (-920.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$1,016,744,000 (12.05%)

$907,405,000 (-18.85%)

$1,118,171,000 (12.11%)

$997,379,000 (0.21%)

Investments Current

$657,371,000 (-27.55%)

$907,405,000 (-18.85%)

$1,118,171,000 (95.51%)

$571,930,000 (-40.58%)

Investments Non-Current

$359,373,000 (0%)

$0 (0%)

$0 (0%)

$425,449,000 (1201.11%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$11,137,000 (17.44%)

$9,483,000 (239.89%)

$2,790,000 (-41.62%)

$4,779,000 (346.22%)

Accumulated Retained Earnings (Deficit)

-$1,538,984,000 (-37.88%)

-$1,116,211,000 (-14.96%)

-$970,987,000 (-50.54%)

-$644,996,000 (-81.99%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$42,288,000 (-5.99%)

$44,981,000 (-25.47%)

$60,350,000 (3.07%)

$58,554,000 (-8.76%)

Debt Current

$0 (0%)

$0 (0%)

$7,318,000 (0%)

$0 (0%)

Debt Non-Current

$42,288,000 (-5.99%)

$44,981,000 (-15.18%)

$53,032,000 (-9.43%)

$58,554,000 (-8.76%)

Total Liabilities

$144,496,000 (17.51%)

$122,963,000 (-70.57%)

$417,812,000 (-5.44%)

$441,871,000 (-2.62%)

Liabilities Current

$102,208,000 (31.07%)

$77,982,000 (-78.57%)

$363,922,000 (-3.79%)

$378,245,000 (427.55%)

Liabilities Non-Current

$42,288,000 (-5.99%)

$44,981,000 (-16.53%)

$53,890,000 (-15.30%)

$63,626,000 (-83.35%)

DNLI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$330,531,000 (204.74%)

$108,463,000 (122.90%)

$48,661,000 (-85.50%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$105,438,000 (2.02%)

$103,354,000 (14.23%)

$90,475,000 (14.44%)

$79,059,000 (31.05%)

Research & Development Expense

$396,440,000 (-6.47%)

$423,876,000 (18.16%)

$358,732,000 (35.19%)

$265,353,000 (24.80%)

Operating Expenses

$487,341,000 (-7.57%)

$527,230,000 (17.37%)

$449,207,000 (30.43%)

$344,412,000 (26.19%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$68,000 (126.67%)

$30,000 (42.86%)

$21,000 (103.65%)

-$575,000 (-169.87%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$422,773,000 (-191.12%)

-$145,224,000 (55.45%)

-$325,991,000 (-12.19%)

-$290,581,000 (-508.49%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$422,773,000 (-191.12%)

-$145,224,000 (55.45%)

-$325,991,000 (-12.19%)

-$290,581,000 (-508.49%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$422,773,000 (-191.12%)

-$145,224,000 (55.45%)

-$325,991,000 (-12.19%)

-$290,581,000 (-508.49%)

Weighted Average Shares

$164,473,772 (19.73%)

$137,370,897 (1.15%)

$135,813,668 (11.21%)

$122,125,581 (1.84%)

Weighted Average Shares Diluted

$164,473,772 (19.73%)

$137,370,897

-

-

Earning Before Interest & Taxes (EBIT)

-$422,705,000 (-191.13%)

-$145,194,000 (55.46%)

-$325,970,000 (-11.96%)

-$291,156,000 (-504.61%)

Gross Profit

$0 (0%)

$330,531,000 (204.74%)

$108,463,000 (122.90%)

$48,661,000 (-85.50%)

Operating Income

-$487,341,000 (-147.76%)

-$196,699,000 (42.27%)

-$340,744,000 (-15.21%)

-$295,751,000 (-571.56%)

DNLI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$88,756,000 (-135.60%)

$249,308,000 (276.33%)

-$141,387,000 (-553.78%)

-$21,626,000 (96.53%)

Net Cash Flow from Financing

$484,304,000 (2617.76%)

$17,820,000 (-94.26%)

$310,670,000 (1505.70%)

$19,348,000 (-96.95%)

Net Cash Flow from Operations

-$347,694,000 (2.88%)

-$357,991,000 (-46.29%)

-$244,716,000 (-15.77%)

-$211,389,000 (-150.80%)

Net Cash Flow / Change in Cash & Cash Equivalents

$47,854,000 (152.67%)

-$90,863,000 (-20.46%)

-$75,433,000 (64.70%)

-$213,667,000 (-149.96%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$72,844,000 (-127.78%)

$262,247,000 (312.25%)

-$123,554,000 (-841.29%)

-$13,126,000 (97.88%)

Capital Expenditure

-$15,912,000 (-22.98%)

-$12,939,000 (27.44%)

-$17,833,000 (-109.80%)

-$8,500,000 (-174.64%)

Issuance (Repayment) of Debt Securities

-$32,338,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$516,642,000 (2799.23%)

$17,820,000 (-94.26%)

$310,670,000 (1505.70%)

$19,348,000 (-96.95%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$102,878,000 (-4.83%)

$108,102,000 (8.27%)

$99,847,000 (17.13%)

$85,247,000 (69.31%)

Depreciation Amortization & Accretion

$8,992,000 (-46.24%)

$16,726,000 (61.09%)

$10,383,000 (20.83%)

$8,593,000 (0.73%)

DNLI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-43.90% (85.40%)

-300.60% (49.67%)

-597.20% (-2916.98%)

EBITDA Margin

-

-38.90% (86.63%)

-291.00% (49.89%)

-580.70% (-2519.58%)

Return on Average Equity (ROAE)

-31.40% (-132.59%)

-13.50% (62.18%)

-35.70% (-27.50%)

-28.00% (-404.35%)

Return on Average Assets (ROAA)

-28.60% (-150.88%)

-11.40% (53.66%)

-24.60% (-24.87%)

-19.70% (-377.46%)

Return on Sales (ROS)

-

-43.90% (85.39%)

-300.50% (49.77%)

-598.30% (-2895.79%)

Return on Invested Capital (ROIC)

-31.60% (-130.66%)

-13.70% (62.87%)

-36.90% (-27.24%)

-29.00% (-384.31%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7.93 (60.83%)

-20.25 (-89.28%)

-10.7 (42.68%)

-18.66 (-114.48%)

Price to Sales Ratio (P/S)

-

8.92 (-74.39%)

34.82 (-68.89%)

111.93 (274.06%)

Price to Book Ratio (P/B)

2.38 (-17.10%)

2.88 (-20.59%)

3.62 (-35.99%)

5.66 (-35.17%)

Debt to Equity Ratio (D/E)

0.12 (-0.84%)

0.12 (-70.32%)

0.4 (-12.64%)

0.46 (16.50%)

Earnings Per Share (EPS)

-2.57 (-142.45%)

-1.06 (59.23%)

-2.6 (-8.79%)

-2.39 (-467.69%)

Sales Per Share (SPS)

0 (0%)

2.41 (201.13%)

0.8 (100.75%)

0.4 (-85.78%)

Free Cash Flow Per Share (FCFPS)

-2.21 (18.11%)

-2.7 (-39.68%)

-1.93 (-7.33%)

-1.8 (-152.29%)

Book Value Per Share (BVPS)

7.48 (-0.39%)

7.5 (-2.21%)

7.67 (-2.60%)

7.88 (-17.87%)

Tangible Assets Book Value Per Share (TABVPS)

8.36 (-0.54%)

8.4 (-21.88%)

10.75 (-6.49%)

11.5 (-14.05%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (65.00%)

-20 (-81.82%)

-11 (38.89%)

-18 (-113.24%)

Enterprise Value Over EBITDA (EV/EBITDA)

-7 (68.69%)

-22.35 (-89.61%)

-11.79 (34.91%)

-18.11 (-114.93%)

Asset Turnover

0 (0%)

0.26 (215.85%)

0.08 (148.48%)

0.03 (-90.12%)

Current Ratio

8.46 (-38.02%)

13.65 (261.87%)

3.77 (58.98%)

2.37 (-88.63%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$363,606,000 (1.97%)

-$370,930,000 (-41.28%)

-$262,549,000 (-19.40%)

-$219,889,000 (-153.23%)

Enterprise Value (EV)

$2,895,003,697 (0.82%)

$2,871,594,358 (-22.82%)

$3,720,409,107 (-27.30%)

$5,117,489,913 (-47.58%)

Earnings Before Tax (EBT)

-$422,705,000 (-191.13%)

-$145,194,000 (55.46%)

-$325,970,000 (-11.96%)

-$291,156,000 (-504.61%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$413,713,000 (-222.04%)

-$128,468,000 (59.29%)

-$315,587,000 (-11.69%)

-$282,563,000 (-451.05%)

Invested Capital

$1,139,300,000 (14.64%)

$993,810,000 (5.88%)

$938,626,000 (18.66%)

$790,994,000 (-27.41%)

Working Capital

$762,228,000 (-22.71%)

$986,155,000 (-2.21%)

$1,008,397,000 (94.30%)

$518,989,000 (-63.55%)

Tangible Asset Value

$1,374,180,000 (19.09%)

$1,153,917,000 (-20.98%)

$1,460,242,000 (3.99%)

$1,404,162,000 (-12.47%)

Market Capitalization

$2,933,122,697 (-1.10%)

$2,965,704,358 (-21.48%)

$3,776,978,107 (-30.66%)

$5,446,800,913 (-45.77%)

Average Equity

$1,347,676,250 (25.28%)

$1,075,704,000 (17.69%)

$914,027,000 (-11.96%)

$1,038,156,500 (34.80%)

Average Assets

$1,477,962,250 (15.79%)

$1,276,443,000 (-3.69%)

$1,325,292,000 (-10.33%)

$1,477,950,250 (47.14%)

Invested Capital Average

$1,339,671,750 (26.61%)

$1,058,111,000 (19.66%)

$884,253,250 (-12.06%)

$1,005,572,750 (43.21%)

Shares

143,921,624 (4.14%)

138,196,848 (1.75%)

135,813,668 (11.21%)

122,125,581 (1.84%)